cedazuridine: Clinical Trials

2 trials of cedazuridine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow cedazuridine: new trials by email Literature Review of cedazuridine trials Research Report on cedazuridine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Azacitidine, ASTX030 (cedazuridine + azacitidine), Cedazuridine - Myelodysplastic Syndromes, Acute Myeloid Leukemia
Phase 2 / Phase 3RecruitingTaiho Oncology, Inc.3162020-05-212026-10-06
Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
ASTX727, Dacogen - Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
Phase 3CompletedAstex Pharmaceuticals, Inc.2272018-02-152024-08-27

Conditions studied

Leukemia, Myeloid, Acute (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Myelodysplastic Syndromes (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Hematologic Diseases (1)  ·  Leukemia (1)

Sponsors

Astex Pharmaceuticals, Inc. (1)  ·  Taiho Oncology, Inc. (1)

Countries

Canada (2)  ·  Czechia (2)  ·  France (2)  ·  Germany (2)  ·  Hungary (2)  ·  Italy (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Austria (1)  ·  Poland (1)

Results publications

PMID 38135371

NIH funding

2018 (1)